EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Filamin A editing in myeloid cells reduces intestinal inflammation and protects from colitis

Riem Gawish iD, Rajagopal Varada iD, Florian Deckert iD, Anastasiya Hladik iD, Linda Steinbichl iD, Laura Cimatti iD, Katarina Milanovic iD, Mamta Jain iD, Natalya Torgasheva iD, Andrea Tanzer iD, Kim De Paepe iD, Tom Van de Wiele iD und 13 weitere

Journal of Experimental Medicine · 2025

DOI: 10.1084/jem.20240109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Riem Gawish und 24 weiteren Autor:innen. Beteiligte Einrichtung: Center of Anatomy and Cell Biology, Division of Cell and Developmental Biology, Medical University of Vienna , Vienna, Austria. Hauptthemen laut MEDLINE: Filamins, Myeloid Cells, Colitis, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patho-mechanistic origins of ulcerative colitis are still poorly understood. The actin cross-linker filamin A (FLNA) impacts cellular responses through interaction with cytosolic proteins. Posttranscriptional A-to-I editing generates two forms of FLNA: genome-encoded FLNAQ and FLNAR. FLNA is edited in colon fibroblasts, smooth muscle cells, and endothelial cells. We found that the FLNA editing status determines colitis severity. Editing was highest in healthy colons and reduced during murine and human colitis. Mice that exclusively express FLNAR were highly resistant to DSS-induced colitis, whereas fully FLNAQ animals developed severe inflammation. While the genetic induction of FLNA editing influenced transcriptional states of structural cells and microbiome composition, we found that FLNAR exerts protection specifically via myeloid cells, which are physiologically unedited. Introducing fixed FLNAR did not hamper cell migration but reduced macrophage inflammation and rendered neutrophils less prone to NETosis. Thus, loss of FLNA editing correlates with colitis severity, and targeted editing of myeloid cells serves as a novel therapeutic approach in intestinal inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FilaminsMyeloid CellsColitisInflammationRNA EditingAnimalsHumansMiceMice, Inbred C57BLNeutrophilsMacrophagesMale

Substanzen

Filamins

Autor:innen und Institutionen

  • Center of Anatomy and Cell Biology, Division of Cell and Developmental Biology, Medical University of Vienna , Vienna, Austria.
  • Department of Medicine I, Research Division of Infection Biology, Medical University of Vienna, Vienna, Austria.
  • Department of Biotechnology, Ghent University, Center for Microbial Ecology and Technology, Ghent, Belgium.
  • Joint Microbiome Facility of the Medical University of Vienna and the University of Vienna , Vienna, Austria.
  • Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Department of Microbiology and Ecosystem Science, University of Vienna, Center for Microbiology and Environmental Systems Science, Vienna, Austria.

ORCID-Profile: Riem Gawish, Rajagopal Varada, Florian Deckert, Anastasiya Hladik, Linda Steinbichl, Laura Cimatti, Katarina Milanovic, Mamta Jain, Natalya Torgasheva, Andrea Tanzer, Kim De Paepe, Tom Van de Wiele, Bela Hausmann, Michaela Lang, Martin Pechhacker, Nahla Ibrahim, Ingrid De Vries, Christine Brostjan, Michael Sixt, Christoph Gasche, Louis Boon, David Berry, Michael F Jantsch, Fatima C Pereira, Cornelia Vesely

Förderung

  • Austrian Science Fund
  • Medical University of Vienna

Zitieren

APA

Gawish, R., Varada, R., Deckert, F., Hladik, A., Steinbichl, L., Cimatti, L., Milanovic, K., Jain, M., Torgasheva, N., Tanzer, A., De Paepe, K., Van de Wiele, T., Hausmann, B., Lang, M., Pechhacker, M., Ibrahim, N., De Vries, I., Brostjan, C., Sixt, M., …, & Vesely, C. (2025). Filamin A editing in myeloid cells reduces intestinal inflammation and protects from colitis. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20240109

Vancouver

Gawish R, Varada R, Deckert F, Hladik A, Steinbichl L, Cimatti L, et al. Filamin A editing in myeloid cells reduces intestinal inflammation and protects from colitis. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20240109

BibTeX
@article{Gawish2025,
  author = {Gawish, Riem and Varada, Rajagopal and Deckert, Florian and Hladik, Anastasiya and Steinbichl, Linda and Cimatti, Laura and Milanovic, Katarina and Jain, Mamta and Torgasheva, Natalya and Tanzer, Andrea and De Paepe, Kim and Van de Wiele, Tom and Hausmann, Bela and Lang, Michaela and Pechhacker, Martin and Ibrahim, Nahla and De Vries, Ingrid and Brostjan, Christine and Sixt, Michael and Gasche, Christoph and Boon, Louis and Berry, David and Jantsch, Michael F and Pereira, Fatima C and Vesely, Cornelia},
  title = {Filamin A editing in myeloid cells reduces intestinal inflammation and protects from colitis},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  doi = {10.1084/jem.20240109}
}
Kostenlos starten →